Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Journal of Molecular Biology|May 20, 1994
Crystallization and preliminary crystallographic data for an FMN-dependent nitroreductase from Escherichia coli BJ V Skelly, P J Collins, R J Knox, et al.Expert Opinion on Investigational Drugs|July 5, 2005
Targeting enzymes to cancers--new developmentsK D Bagshawe, P J Burke, R J Knox, et al.Structure (London, England : 1993)|March 15, 1997
Crystal structure of carboxypeptidase G2, a bacterial enzyme with applications in cancer therapyS Rowsell, R A Pauptit, A D Tucker, et al.British Journal of Cancer|January 1, 1995
Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibodyD Marshall, R B Pedley, R G Melton, et al.British Journal of Cancer|March 1, 1996
Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibodyD Marshall, R B Pedley, J A Boden, et al.Biochemical Pharmacology|December 15, 1992
The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--I. Purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)G M Anlezark, R G Melton, R F Sherwood, et al.Cancer Research|August 17, 2000
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapyR J Knox, T C Jenkins, S M Hobbs, et al.Journal of Immunological Methods|January 14, 1993
Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2R G Melton, J M Boyle, G T Rogers, et al.British Journal of Cancer|January 26, 2005
Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failureS Buchen, D Ngampolo, R G Melton, et al.Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
In vitro and in vivo comparison of a randomly coupled antibody fragment-enzyme conjugate with a site-specific conjugateR C Werlen, R E Offord, D C Blakey, et al.Pageof 4